Singlepatient trials determine statin tolerability
HealthDayIn patients with statinrelated myalgia singlepatient randomized trials of statin and placebo can determine whether the myalgia is actually due to the statin according to a small study...
View ArticleNew ACCAHA CVRisk Calculator Hits Europeans Twice as Hard
Hypothetically in Switzerland the controversial risk calculator vs current ESC criteria would double the population appropriate for statin therapy as well as its costs an analysis suggests. Heartwire
View ArticleSinglepatient trials helpful in determining statin tolerability
Singlepatient or nof1 trials may be a useful method for determining which patients are experiencing true statinrelated discomfort and which patients may be able to continue therapy according to an...
View ArticleEsperion Therapeutics Provides ETC1002 Program Update; Reports Fourth Quarter...
Conference Call and Webcast Today Wednesday March 5 2014 at 430 p.m. Eastern Time Esperion Therapeutics Inc. NASDAQ ESPR a clinicalstage biopharmaceutical company focused on developing and...
View ArticleOMICS Group International Cardiology Conference 2014 to be held from April...
OMICS Group Conferences a leading scientific event organizer is pleased to announce its 4th International Conference on Clinical & Experimental Cardiology April 1416 2014 at Hilton San Antonio...
View ArticleStatins May Lower Blood Clot Risk Following Joint Replacement Surgery
NEW ORLEANS March 11 2014 PRNewswireUSNewswire Statins have long been known to lower cholesterol and more recently to decrease the risk of deep vein thrombosis blood clots in healthy nonsurgical...
View ArticleLipitor Lawsuits Consolidated in South Carolina Federal Court for Pretrial...
Court Documents Indicate 68 Lipitor Diabetes Claims Are Now Pending in New Multidistrict Litigation Additional Lipitor Lawsuits Expected to Be Transferred to South CarolinaColumbus Ohio PRWEB March 11...
View ArticlePfizer Lipitor OTC Bid Would Face An FDA Evolving On Switch Innovation
Pfizer looks to lessons from prior statin attempts and an environment open to new ways to inform consumer decisions as it considers filing for a Lipitor switch which will depend on the outcome of a...
View ArticleThe Zacks Analyst Blog Highlights Sanofi Regeneron Amgen InterMune and XOMA
CHICAGO March 13 2014 PRNewswire &160;Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting...
View ArticleStatins side effects are minimal study argues
CholesterolloweringÂstatins have almost no side effects The Guardian reports. A new UK study argues that the majority of reported side effects are actually due to the nocebo effectÂÂsymptoms that are...
View ArticleStatin sideeffects questioned
BBC &8211; Drugs taken to lower the risk of heart attacks and strokes may have fewer sideeffects than claimed researchers say. Their review of 83880 patients published in the European Journal of...
View ArticleAmgen Announces Positive TopLine Results From Phase 3 TESLA Trial Of...
THOUSAND OAKS Calif. March 17 2014 PRNewswire Amgen NASDAQAMGN today announced that the Phase 3 TESLA Trial Evaluating PCSK9 Antibody in Subjects with LDL Receptor Abnormalities trial evaluating...
View ArticleStatin Use and Incident Prostate Cancer Risk
The longterm use of certain types of statins may decrease the risk of prostate cancer a new study suggests. Prostate Cancer and Prostatic Diseases
View ArticleStatin Side Effects Linked To CholesterolRelated Locus
A group of researchers from the University of Chicago Seattle&39;s Sage Bionetworks the Children&39;s Hospital Oakland Research Institute and others have located a new cholesterolrelated locus...
View ArticleAmgen reports evolocumab data in hoFH
Amgen Inc. NASDAQAMGN said oncemonthly subcutaneous evolocumab AMG 145 met the primary endpoint of a greater percent reduction in LDLC from baseline to week 12 vs. placebo in the doubleblind Phase III...
View ArticleMost statin "side effects" not attributable to the drug study suggests
Most supposed statin side effects are not actually caused by the drug say the authors of a systematic review published in the European Journal of Preventive Cardiology online 12 March 2014. By...
View ArticleAmgen cholesterol drug hits trial target
A new treatment for patients with extremely high cholesterol levels has hit its primary endpoint but Amgen has held back from releasing the top line data.A phase III trial of evolocumab found the drug...
View ArticleStatin may slow untreatable progressive stage of multiple sclerosis
Simvastatin a cheap cholesterol lowering drug might be a potential treatment option for the secondary progressive or chronic stage of multiple sclerosis which is currently untreatable results of a...
View ArticleThe Lancet Statin may slow untreatable progressive stage of multiple sclerosis
Results of a phase 2 study published in The Lancet suggest that simvastatin a cheap cholesterol lowering drug might be a potential treatment option for the secondary progressive or chronic stage of...
View ArticleStatins may slow progression of MS
Multiple sclerosis patients may benefit from statins The Guardian reports. A UK study involving 140 participants has found that statins which lower cholesterolÂmay slow brain shrinkage in people living...
View Article